Activists allege EU used Monsanto-funded studies to approve Roundup use

Roundup glyphosate Monsanto 375x121 Activists allege EU used Monsanto funded studies to approve Roundup useA key study used to show the safety of Monsanto’s glyphosate-based weed killer Roundup to persuade the European Union to approve its use may have been plagiarized in part from Monsanto-funded studies, an alliance of activists alleged.

Green members claim that they found “clear evidence” of the German Federal Institute for Risk Assessment (BfR)’s “deliberate pretense of an independent assessment, whereas in reality the authority was only echoing the industry applicants’ assessment.”

The German regulator issued reports in 2014 and 2015 concluding that available data didn’t show that glyphosate, the active ingredient in Roundup, was carcinogenic. However, in 2015, the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as a probable carcinogen, adding that it found “limited evidence of carcinogenicity in humans for non-Hodgkin lymphoma. The evidence in humans is from studies of exposures, mostly agricultural, in the USA, Canada and Sweden published since 2001. In addition, there is convincing evidence that glyphosate also can cause cancer in laboratory animals.”

In August, in a landmark case brought by a school groundskeeper who claimed exposure to Roundup caused his terminal non-Hodgkin lymphoma diagnosis, a  California jury ordered Monsanto to pay the man $289 million in damages. The verdict was slashed to $78 million. Monsanto now faces more than 9,000 similar lawsuits in the United States.

Earlier this month, a French court banned Monsanto’s Roundup Pro 360 weed killer based on “potential health risks.”

Bayer AG, which acquired Monsanto in June, is standing by the safety of glyphosate.

Source: Genetic Literacy Project